Beranda › Kanker Rektum › Washington › Seattle
Uji klinis Kanker Rektum di Seattle, WA
9 studi untuk Kanker Rektum mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Menerima pesertaSukarelawan sehat diterima
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi jauhnya
Family Communications After Genetic Testing
Menerima pesertaSukarelawan sehat diterima
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- dan 1 lainnya
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Menerima pesertaFase 3
- Fred Hutchinson Cancer Center ( Site 0076), Seattle
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
Menerima pesertaStudi observasional
- Fred Hutch, Seattle
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Menerima peserta
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi jauhnya
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Menerima pesertaFase 3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Fred Hutch Cancer Center, Seattle
Uji klinis Kanker Rektum di kota lain
- New York City, NY17 studi
- Boston, MA12 studi
- Houston, TX11 studi
- St. Louis, MO11 studi
- Columbus, OH10 studi
- Los Angeles, CA10 studi
- Tampa, FL9 studi
- Nashville, TN9 studi
- Rochester, MN8 studi
- Chicago, IL8 studi
- Edison, NJ8 studi
- Salt Lake City, UT8 studi
Studi lain di Seattle
- Kanker Paru Non-Sel Kecil53 studi
- Kanker (semua jenis)49 studi
- Kanker Prostat42 studi
- Leukemia Mieloid Akut40 studi
- Kanker Payudara39 studi
- Kanker Metastatik39 studi
- Kanker Kolorektal34 studi
- Kanker Paru33 studi
- Kanker Ovarium30 studi
- Mieloma Multipel22 studi
- Sindrom Mielodisplastik21 studi
- Leukemia Limfoblastik Akut21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.